Raidium
Radiology augmented GPT for precision medicine.
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- Deep Tech
- SaaS
- Hôpital-Saint-Louis, Paris, France
Jump to section
Company mission
Advancing precision medicine by promoting access to imaging biomarkers.
Our take
Medical imaging - radiology - has seen the most AI advancements in medicine out of all other sectors. This makes sense; AI’s analytical skills are perfectly matched for pinpointing diseases from medical images. This paradigm shift has paved the way for exciting new technologies that help radiologists get results quicker.
Raidium’s interactive AI platform advances precision medicine through multimodal foundational large language models. With partners across the French medical science industry and deeptech companies, Raidium accelerates the rate of diagnoses through secure data collation and analysis. Its refreshing aim is to make its platform accessible to medical professionals.
2025 funding will help the company launch its "GPT For Radiology" platform, whilst support from Swiss pharmaceutical testing leader Debiopharm will accelerate its growth.
Freddie
Company Specialist at Welcome to the Jungle
Leadership
Paul Herent
(Co-Founder & CEO)Previously Radiologue and Consultant and Owkin.
Pierre Manceron
(Co-Founder)Previously a Freelancer for Argyron, Senior AI Researcher at Aqemia, Group Lead at Owkin and Research Intern at Inria.